Fares Alahdab

149.2k total citations · 3 hit papers
116 papers, 4.0k citations indexed

About

Fares Alahdab is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Fares Alahdab has authored 116 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Surgery, 24 papers in Cardiology and Cardiovascular Medicine and 18 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Fares Alahdab's work include Cardiac Imaging and Diagnostics (15 papers), Meta-analysis and systematic reviews (10 papers) and Health and Medical Research Impacts (8 papers). Fares Alahdab is often cited by papers focused on Cardiac Imaging and Diagnostics (15 papers), Meta-analysis and systematic reviews (10 papers) and Health and Medical Research Impacts (8 papers). Fares Alahdab collaborates with scholars based in United States, Syria and United Kingdom. Fares Alahdab's co-authors include M. Hassan Murad, Noor Asi, Mouaz Alsawas, Larry J. Prokop, Zhen Wang, Khaled Mohammed, Khalid Benkhadra, Wigdan Farah, Jehad Almasri and Shrikant Tamhane and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Fares Alahdab

107 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

New evidence pyramid

2016 768 citations M. Hassan Murad, Noor Asi et al. Evidence-Based Medicine profile →
Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta‐analysis

2015 391 citations Jehad Almasri, Fares Alahdab et al. profile →
Efficacy of Pharmacological Therapies for the Prevention of Fractures in Postmenopausal Women: A Network Meta-Analysis

2019 214 citations Noor Asi, Fares Alahdab et al. profile →

Peers

Countries citing papers authored by Fares Alahdab

Since Specialization

Citations

This map shows the geographic impact of Fares Alahdab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fares Alahdab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fares Alahdab more than expected).

Fields of papers citing papers by Fares Alahdab

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fares Alahdab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fares Alahdab. The network helps show where Fares Alahdab may publish in the future.

Co-authorship network of co-authors of Fares Alahdab

This figure shows the co-authorship network connecting the top 25 collaborators of Fares Alahdab. A scholar is included among the top collaborators of Fares Alahdab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fares Alahdab. Fares Alahdab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Potential risks of GenAI on medical education 2025 ·BMJ evidence-based medicine ·(unknown), (unknown), (unknown), Fares Alahdab	1
2	AI in healthcare: an introduction for clinicians 2025 ·BMJ evidence-based medicine ·(unknown), Samer Alabed, G. E. Kawika Allen, Fares Alahdab	0
3	Development and validation of a machine learning model to predict myocardial blood flow and clinical outcomes from patients’ electrocardiograms 2024 ·Cell Reports Medicine ·Fares Alahdab, Maliazurina B. Saad, Ahmed Ibrahim Ahmed, (unknown), Muhammad Aminu, Yushui Han, Jonathan B. Moody, Venkatesh L. Murthy, Jia Wu, Mouaz H. Al‐Mallah	5
4	Myocardial Blood Flow Reserve, Microvascular Coronary Health, and Myocardial Remodeling in Patients With Aortic Stenosis 2024 ·Journal of the American Heart Association ·Fares Alahdab, Ahmed Ibrahim Ahmed, (unknown), Yushui Han, Ola Abdelkarim, (unknown), Stephen H. Little, Michael J. Reardon, (unknown), Sachin S. Goel, Mohamad Alkhouli, William A. Zoghbi, Mouaz H. Al‐Mallah	2
5	Prognostic value of global myocardial flow reserve in patients with history of coronary artery bypass grafting 2023 ·European Heart Journal - Cardiovascular Imaging ·Mahmoud Al Rifai, Ahmed Ibrahim Ahmed, (unknown), Fares Alahdab, Faisal Nabi, Mouaz H. Al‐Mallah	7
6	Potential impact of large language models on academic writing 2023 ·BMJ evidence-based medicine ·Fares Alahdab	5
7	Patient-level explainable machine learning to predict major adverse cardiovascular events from SPECT MPI and CCTA imaging 2023 ·PLoS ONE ·Fares Alahdab, Radwa El Shawi, Ahmed Ibrahim Ahmed, Yushui Han, Mouaz H. Al‐Mallah	11
8	Medical Research Conduct and Publication during Higher Education in Syria: Attitudes, Barriers, Practices, and Possible Solutions 2022 ·SHILAP Revista de lepidopterología ·Ibrahem Hanafi, (unknown), (unknown), (unknown), (unknown), Mohammad Y Hajeer, (unknown), Fares Alahdab	3
9	Systematic review of electronic health records to manage chronic conditions among displaced populations 2022 ·BMJ Open ·(unknown), Henry Ashworth, (unknown), Sara Dada, (unknown), S Ebrahim, (unknown), Jordan Lebovic, (unknown), Larry J. Prokop, (unknown), (unknown), Fares Alahdab	6
10	Risk Factors for Mortality and Ventricular Tachycardia in Patients With Repaired Tetralogy of Fallot: A Systematic Review and Meta-analysis 2020 ·Canadian Journal of Cardiology ·Mathias Possner, Stephanie Y. Tseng, Fares Alahdab, Jouke P. Bokma, Adam M. Lubert, Paul Khairy, M. Hassan Murad, Walid Ben Ali, Larry J. Prokop, Richard J. Czosek, Gruschen Veldtman, Tarek Alsaied	26
11	Community-Engaged Approaches for Minority Recruitment Into Clinical Research: A Scoping Review of the Literature 2020 ·Mayo Clinic Proceedings ·Mark L. Wieland, Jane W. Njeru, Fares Alahdab, Chyke A. Doubeni, Irene G. Sia	52
12	Evidence maps: a tool to guide research agenda setting 2019 ·BMJ evidence-based medicine ·Fares Alahdab, M. Hassan Murad	19
13	American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease 2019 ·Blood Advances ·Robert I. Liem, Sophie Lanzkron, Thomas D. Coates, Laura DeCastro, Ankit A. Desai, Kenneth I. Ataga, Robyn T. Cohen, Johnson Haynes, Ifeyinwa Osunkwo, Jeffrey D. Lebensburger, James P. Lash, Theodore Wun, Madeleine Verhovsek, (unknown), (unknown), Fares Alahdab, Abdulrahman Katabi, Reem A. Mustafa	95
14	Diagnostic accuracy of the McGill thyroid nodule score in paediatric patients 2018 ·Clinical Endocrinology ·Ana L. Creo, Fares Alahdab, Alaa Al Nofal, Kristen B. Thomas, Amy B. Kolbe, Siobhán T. Pittock	7
15	Outcomes of Transcatheter Versus Surgical Aortic Valve Implantation for Aortic Stenosis in Patients With Hepatic Cirrhosis 2017 ·The American Journal of Cardiology ·Fahad Alqahtani, Sami Aljohani, (unknown), Fares Alahdab, Akram Kawsara, David R. Holmes, Mohamad Alkhouli	18
16	Nonselective β-Blockers and Survival in Patients With Cirrhosis and Ascites: A Systematic Review and Meta-analysis 2016 ·Clinical Gastroenterology and Hepatology ·Sakkarin Chirapongsathorn, Nelson Valentin, Fares Alahdab, Chayakrit Krittanawong, Patricia J. Erwin, M. Hassan Murad, Patrick S. Kamath	52
17	Interpreting meta-analysis of continuous outcomes with pre and postvalues 2016 ·Evidence-Based Medicine ·Fares Alahdab, Feras Zaiem, Zhen Wang, M. Hassan Murad	3
18	Natural language processing: use in EBM and a guide for appraisal 2016 ·Evidence-Based Medicine ·Mouaz Alsawas, Fares Alahdab, Noor Asi, (unknown), Zhen Wang, M. Hassan Murad	10
19	Oncologic surveillance in bladder cancer following radical cystectomy: A systematic review and meta-analysis 2016 ·Urologic Oncology Seminars and Original Investigations ·Suzanne B. Stewart‐Merrill, Fares Alahdab, Khalid Benkhadra, Zhen Wang, Atsushi Sorita, Stephen A. Boorjian, Igor Frank, M. Hassan Murad	8
20	Early studies reported extreme findings with large variability: a meta-epidemiologic study in the field of endocrinology 2015 ·Journal of Clinical Epidemiology ·Zhen Wang, Fares Alahdab, Jehad Almasri, Qusay Haydour, Khaled Mohammed, Abd Moain Abu Dabrh, Larry J. Prokop, (unknown), (unknown), Víctor M. Montori, M. Hassan Murad	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact